Given the importance of TRPA1 and TRPV1 nociceptive sensory neurons in colitis-mediated nociception [1,10,11,12,13], the targeted inhibition of these nociceptors can be a promising therapeutic strategy for alleviation of IBD-associated pain. This evidence concerns the gene TRPA1 and colitis.